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Acute viral laryngotracheitis, the so-called “croup,” is awidely known disease in pediatric medicine. Unlessthere are no signs of respiratory distress, children aretreated ambulatory. Few of them require hospitaliza-
tion and only 1% must be intubated because of respiratory failure.1
Bacterial pneumonia may complicate viral laryngotracheitis and
adversely influence outcome. Even properly managed, viral laryn-
gotracheitis can occasionally result in death, particularly in young
infants.2
Clinical Summary
A 14-month-old male infant (8.7 kg, 80 cm, body surface area
0.43 m2) had symptoms of a common cold but had to be
hospitalized because of rapid deterioration of his general condi-
tion and severe respiratory distress syndrome. Despite treatment
with oxygen, humidified air, inhalational epinephrine, and intra-
venous corticosteroids, he had to be intubated because of respira-
tory failure. Bilateral pleural effusions were drained. Oxygenation
did not improve and conventional ventilation was switched to
high-frequency oscillatory ventilation plus nitric oxide. Soon after,
the child required increasing vasoactive support, and finally in-
tractable septic shock and heart failure developed. Arterial satura-
tion was between 70% and 78%.
Extracorporeal circulatory support with oxygenation was found
to be the last chance for this child. It was performed with a new
micro-diagonal pump (DeltaStream DP-II; Medos, Stolberg, Ger-
many). Cervical cannulation with the common carotid artery (8F
cannula) and the internal jugular vein (14F cannula) was per-
formed for vascular access.
Microbiologic assessment of sputum revealed parainfluenza
and Staphylococcus aureus. Antibiotic regimen consisted of cefu-
roxime, amikacin, vancomycin, and clarithromycin.
The DeltaStream DP2 di-
agonal pump is a mini-rota-
tional pump with a diagonally
streamed impeller (100–
10,000U/min), which, by the
decoupling of pump head and
drive, enables a nonpulsatile
application comparable with
a standard centrifugal pump (Figures 1 and 2). The DP2 pump (75
 41 mm) has an extremely low priming volume of 17 mL. A
variation of the impeller design has been performed to optimize
hydraulic characteristics and reduce blood flow damage. The pump
allows flow (up to 8 L/min) and pressure generation for cardio-
pulmonary bypass applications.3,4 The preload control prevents an
aspiration of the cannula. The zero-flow mode allows direct inter-
ruption of the blood flow by reducing the rotational speed and so
prevents an unintentional backflow. Additional safety features
include a flow-measuring sensor with integrated bubble detector,
four pressure sensors to be placed freely, as well as a level sensor
for open cardiopulmonary bypass use.
Oxygenation was performed through a Polystan Safe Mini
(Maquet, Hirrlingen, Germany) bioline-coated oygenator with in-
tegrated heat exchanger. Kaolin-activated anticlotting time was
monitored every 2 hours with the HaemoTec system (Medtronic
Inc, Englewood, NJ). Activated clotting time was targeted between
180 and 200 seconds.
Discussion
During the first 12 hours, extracorporeal membrane oxygenation
(ECMO) was performed with a perfusion flow index of 2.8 L/m2..
Complete biventricular unloading favorably influenced the recov-
ery of hypoxic/septic myocardial failure. Vasoactive medication
was rapidly reduced and stopped.
Surprisingly, renal function did not deteriorate significantly
during support (maximal serum creatinine 47 mg/dL, urea 11.8
mmol/L). After 36 hours of full support, stepwise reduction of the
arterial pump flow (200 mL/4 hours) allowed to increasingly load
the heart and re-establish lung perfusion. Mechanical ventilation
was restarted and pump flow could be stopped after 52 hours of
support. No thrombembolic or bleeding events occurred during
support. Platelet count was stable around 70,000 and only 1 unit of
red blood cells and 1 unit of fresh frozen plasma were transfused.
Periodical clinical neurologic examination and continuous elec-
troencephalographic monitoring were performed during ECMO
support and did not show any abnormalities. On awaking, the child
had focal contractions of the left hand and a discrete left-sided
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hemiparesis. Cerebral computed tomographic scan revealed a
small ischemic area in the right cortex. The child was extubated
after 12 days and discharged 1 month after admission. At 1-year
follow-up, the boy demonstrated a normal health status without
neurologic residua.
ECMO support with the DP2 micro-diagonal pump allowed
successful rescue of this dramatic case of laryngotracheobronchitis
complicated by respiratory and circulatory failure.
The perfusion was performed without complications. The sys-
tem heparin-coating of the oxygenator and the tubing system may
have contributed to decrease procoagulant activity and need for
heparin.5
References
1. Geelhoed GC. Sixteen years of croup in a Western Australian teaching
hospital: effects of routine steroid treatment. Ann Emerg Med. 1996;28:
621-6.
2. Fisher JD. Out-of-hospital cardiopulmonary arrest in children with
croup. Pediatr Emerg Care. 2004;20:35-6.
3. Agati S, Mignosa C, Ciccarello G, Dario S, Undar A. Pulsatile ECMO
in neonates and infants: first European experience with a new device.
ASAIO J. 2005;51:508-12.
4. Göbel C, Arvand A, Eilers R, Marseille O, Bals C, Meyns B, et al.
Development of the MEDOS/HIA Delta Stream extracorporeal rotary
blood pump. Artif Organs. 2001;25:358-65.
5. Cornish JD, Clark RH, Ricketts RR, Dykes FD, Wright JA, Kesser K,
et al. Extracorporeal membrane oxygenation service at Egleston: two
years experience. J Med Assoc. 1993;83:471-6.
Figure 1. Line drawing of the DP 2 microdiagonal pump (A)
showing the optimal washout mechanism due to the holes in the
rotator (B).
Figure 2. Picture of the extracorporeal circulatory and oxygen-
ation system with the DeltaStream micro-diagonal pump.
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